Ben Tre Pharmaceutical JSC
VN:DBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Ben Tre Pharmaceutical JSC
VN:DBT
|
VN |
|
M
|
Mithra Pharmaceuticals SA
F:1TM
|
BE |
|
E
|
Enanta Pharmaceuticals Inc
F:9EP
|
US |
|
V
|
Volatus Capital Corp
F:VOY0
|
CA |
|
C
|
Cresco Labs Inc
CNSX:CL
|
US |
|
D
|
Diguang International Development Co Ltd
OTC:DGNG
|
CN |
|
Metrospaces Inc
OTC:MSPC
|
US |
|
M
|
MCS Steel PCL
SET:MCS
|
TH |
|
L
|
Lentex SA
F:0KM
|
PL |
|
R
|
Reply SpA
F:REJA
|
IT |
|
A
|
Aura Minerals Inc
F:A531
|
US |
|
M
|
Middle Island Resources Ltd
F:M83
|
AU |
|
K
|
K&S AG
DUS:SDF
|
DE |
Dividends
Dividend Yield
Ben Tre Pharmaceutical JSC
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Ben Tre Pharmaceutical JSC
Payout Ratio
Ben Tre Pharmaceutical JSC
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for DBT is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
DBT Price
Ben Tre Pharmaceutical JSC
| Average Annual Return | -49.78% |
| Standard Deviation of Annual Returns | 36.39% |
| Max Drawdown | -98% |
| Market Capitalization | 291.1B VND |
| Shares Outstanding | 21 970 000 |
| Percentage of Shares Shorted |
N/A
|
DBT Return Decomposition
Main factors of price return
Stock Splits
DBT's latest stock split occurred on Sep 19, 2025
The company executed a 107-for-100 stock split, meaning that for every 100 shares held, investors received 107 new shares.
Before the split, DBT traded at 12149.9945 per share. Afterward, the share price was about 11700.
The adjusted shares began trading on Sep 19, 2025. This was stock split number 4 in DBT's history, following the previous one in Jul 5, 2024.
